Table 3.
The most significant associations of single SNPs with heroin addiction
| a. | |||||||
|---|---|---|---|---|---|---|---|
| SNP | Gene | Allele test | Genotype testa | Effect of the minor allele | |||
| P - Value | OR (95% CI) | P- Value | |||||
| US only | Combined | Combined | US only | Combined | |||
| Group 1 | |||||||
| rs510769 | OPRM1 | 0.0003 | 0.0008 | 1.7 (1.2–2.2) | 0.001 | 0.0029 | risk |
| rs3778151 | OPRM1 | 0.0007 | 0.003 | 1.7 (1.2–2.4) | 0.003 | 0.015 | risk |
| rs6473797 | OPRK1 | 0.0009 | 0.004 | 0.7 (0.5–0.9) | 0.003 | 0.011 | protection |
| rs1534891 | CSNK1E | 0.0016 | 0.002 | 0.6 (0.4–0.8) | 0.002 | 0.001 | protection |
| rs694066 | GAL | 0.0019 | 0.001 | 2.1 (1.3–3.6) | 0.006 | 0.004 | risk |
| rs2236861 | OPRD1 | 0.0029 | 0.002 | 1.6 (1.7–2.2) | 0.003 | 0.003 | risk |
| Group 2 | |||||||
| rs3766951 | OPRD1 | 0.0125 | 0.009 | 1.4 (1.1–1.9) | 0.040 | 0.030 | risk |
| rs2236857 | OPRD1 | 0.0165 | 0.008 | 1.5 (1.1–1.9) | 0.019 | 0.005 | risk |
| rs3758987 | HTR3B | 0.0174 | 0.007 | 1.5 (1.1–2.0) | 0.049 | 0.019 | risk |
| b. SNP location | |||||
|---|---|---|---|---|---|
| SNP | Gene Symbol | Gene | Gene Location | Chr. | Position Build 36.2 |
| rs510769 | OPRM1 | mu opioid receptor | intron 1 | 6 | 154403712 |
| rs3778151 | OPRM1 | mu opioid receptor | intron 1 | 6 | 154435373 |
| rs6473797 | OPRK1 | kappa opioid receptor | intron 2 | 8 | 54315535 |
| rs1534891 | CSNK1E | casein kinase 1, epsilon | intron 7 | 22 | 37025045 |
| rs694066 | GAL | galanin | intron 2 | 11 | 68209561 |
| rs2236861 | OPRD1 | delta opioid receptor | intron 1 | 1 | 29012343 |
| rs2236857 | OPRD1 | delta opioid receptor | intron 1 | 1 | 29034196 |
| rs3766951 | OPRD1 | delta opioid receptor | intron 1 | 1 | 29042146 |
| rs3758987 | HTR3B | serotonin receptor 3B | −381 | 11 | 113280485 |
additive mode of inheritance.